Clinical trial
SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent…
NCT00180479 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00180479 |
|---|---|
| Title | SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) |
| Official title | SPIRIT III: A Clinical Evaluation of the Investigational Device XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) in the Treatment of Subjects With de Novo Native Coronary Artery Lesions |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stents, Coronary Artery Disease, Total Coronary Occlusion, Coronary Artery Restenosis, Stent Thrombosis, Vascular Disease, Myocardial Ischemia, Coronary Artery Stenosis |
| Intervention type | Device |
| Interventions | XIENCE V® Everolimus Eluting Coronary Stent, TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent |
| Enrollment | 1,002 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Nov 1, 2011 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 23, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: